Registered entities
Axonics, Inc
Reg. No. 05115951United States
AXONICS MODULATION TECHNOLOGIES, INC
Reg. No. 454744083United States
Axonics Modulation Technologies, Inc.
Reg. No. 1603756United States
Axonics Modulation Technologies, Inc
Reg. No. 20188007110United States
Innovation
38 patent families (30 granted) — focus: Human necessities, Electricity & electronics, Physics & computing; filing pace steady. Cited 17,678 times.
| Year | Filings |
|---|---|
| 2016 | 1 |
| 2017 | 1 |
| 2018 | 2 |
| 2020 | 1 |
| 2021 | 7 |
| 2022 | 10 |
| 2023 | 16 |
| 2024 | 16 |
| 2025 | 17 |
| 2026 | 5 |
Investor mix
11 investors on record; lead investors include Longitude Capital, Advent Life Sciences, NeoMed, Legend Capital; 2 have since exited.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 3 | 27% |
| Private equity | 3 | 27% |
| Accelerator & incubator | 1 | 9% |
| Bank & private debt | 1 | 9% |
| Other / undisclosed | 3 | 27% |